What is the clinical evidence from this study?

Study design: Observational. Population: COVID-19 (n=1220). Intervention: Genetic variants (e.g., 3p21.31 locus) vs. Non-carriers / ambulatory mild COVID-19 cases. Primary outcome: Severe COVID-19 (hospitalized severe vs ambulatory mild) (OR 4.03, 95% CI 2.56-6.37, p=0.0000000021).

What does this research mean for the field?

The common lead variant at the 3p21.31 locus is strongly associated with severe COVID-19, and polygenic risk scores accurately capture risk in an age-dependent manner. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

December 23, 2024PLoS PathogensOpen Access

Systematic assessment of COVID-19 host genetics using whole genome sequencing data

View Full Paper

Ask AI

Bookmark

Key result

The 3p21.31 locus variant is linked to ~303% higher severe COVID-19 risk.

OR 4.03
95% CI 2.56-6.37
P=0.0000000021
n=1,220

Why the study?

Cohort-based joint analyses of variants from the entire allelic spectrum in individuals with confirmed SARS-CoV-2 infections were lacking to understand host genetic contributions to COVID-19 variability.

Population

1,220 mainly vaccine-naïve individuals with confirmed SARS-CoV-2 infection including 827 hospitalized cases

Comparison

Genetic variant burden and polygenic risk scores in COVID-19 cases versus controls or within subgroups

Design

Observational cohort study using whole genome sequencing

Authors

ASAxel SchmidtUniversity of Bonn NCNicolas CasadeiBernstein Center for Computational Neuroscience Tübingen FBFabian BrandUniversity Hospital Bonn

Discussion

Member takes

Overview

May refine age-specific COVID-19 risk prediction; leaves open clinical utility pending prospective validation.

Study Design

Type

Observational (n=1,220)

Multicenter

Yes

Structured PICO

Population

1,220 mainly vaccine-naïve individuals with confirmed SARS-CoV-2 infection, including 827 hospitalized cases, aged 1 to 100 years.

Exposure

Whole genome sequencing

Outcome

Genetic variants associated with COVID-19 severity and hospitalization

Main Result

Odds Ratio: 4.03 (95% CI 2.56–6.37)

p-value: p=0.0000000021

Whole genome sequencing of COVID-19 patients confirms known risk loci such as 3p21 and highlights the role of rare variants in interferon immune response genes and polygenic risk scores in disease severity.

Limitations

Limited sample size for robust identification of low-frequency and rare risk variants
Use of the WHO classification system as a proxy phenotype for severity likely increased classification heterogeneity, limiting statistical power
Underpowered to detect rare autosomal recessive inborn errors of immunity in specific subgroups like children

Cite This Study

Schmidt et al. (2024) conducted an observational in COVID-19 (n=1,220). Genetic variants (e.g., 3p21.31 locus) vs. Non-carriers / ambulatory mild COVID-19 cases was evaluated on Severe COVID-19 (hospitalized severe vs ambulatory mild) (OR 4.03, 95% CI 2.56-6.37, p=0.0000000021). The common lead variant at the 3p21.31 locus was strongly associated with severe COVID-19 (OR 4.03), and polygenic risk scores accurately captured risk in an age-dependent manner.

synapsesocial.com/papers/6aad01a67d73f5c241a304c4 https://doi.org/10.1371/journal.ppat.1012786

View Full Paper

Ask AI

Bookmark

December 23, 2024PLoS PathogensOpen Access

Systematic assessment of COVID-19 host genetics using whole genome sequencing data

View Full Paper

Ask AI

Bookmark

Key result

The 3p21.31 locus variant is linked to ~303% higher severe COVID-19 risk.

OR 4.03
95% CI 2.56-6.37
P=0.0000000021
n=1,220

Why the study?

Population

1,220 mainly vaccine-naïve individuals with confirmed SARS-CoV-2 infection including 827 hospitalized cases

Comparison

Genetic variant burden and polygenic risk scores in COVID-19 cases versus controls or within subgroups

Design

Observational cohort study using whole genome sequencing

Authors

ASAxel SchmidtUniversity of Bonn NCNicolas CasadeiBernstein Center for Computational Neuroscience Tübingen FBFabian BrandUniversity Hospital Bonn

Discussion

Member takes

Overview

May refine age-specific COVID-19 risk prediction; leaves open clinical utility pending prospective validation.

Study Design

Type

Observational (n=1,220)

Multicenter

Yes

Structured PICO

Population

1,220 mainly vaccine-naïve individuals with confirmed SARS-CoV-2 infection, including 827 hospitalized cases, aged 1 to 100 years.

Exposure

Whole genome sequencing

Outcome

Genetic variants associated with COVID-19 severity and hospitalization

Main Result

Odds Ratio: 4.03 (95% CI 2.56–6.37)

p-value: p=0.0000000021

Limitations

Limited sample size for robust identification of low-frequency and rare risk variants
Use of the WHO classification system as a proxy phenotype for severity likely increased classification heterogeneity, limiting statistical power
Underpowered to detect rare autosomal recessive inborn errors of immunity in specific subgroups like children

Cite This Study

synapsesocial.com/papers/6aad01a67d73f5c241a304c4 https://doi.org/10.1371/journal.ppat.1012786

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark